---
title: "European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276764674.md"
description: "European equities traded in the US as American depositary receipts were little changed, edging up 0.01% to 1,839.63 on the S&P Europe Select ADR Index. Notable gainers included Criteo (CRTO) and DBV Technologies (DBVT), rising 2.6% and 2.1%, respectively. Decliners included Telefonica (TEFOF) and Novo Nordisk (NVO), dropping 3.8% and 2.4%. From the UK and Ireland, Autolus Therapeutics (AUTL) and Akari Therapeutics (AKTX) led gains with increases of 7.8% and 6.1%, while Biodexa Pharmaceuticals (BDRX) and Lloyds Banking Group (LYG) were among the decliners, falling 2.9% and 1.3%."
datetime: "2026-02-24T16:03:00.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276764674.md)
  - [en](https://longbridge.com/en/news/276764674.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276764674.md)
---

# European Equities Traded in the US as American Depositary Receipts Little Changed in Tuesday Trading

11:03 AM EST, 02/24/2026 (MT Newswires) -- European equities traded in the US as American depositary receipts were little changed late Tuesday morning, edging 0.01% higher to 1,839.63 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo ( CRTO ) and biopharmaceutical company DBV Technologies ( DBVT ) , which rose 2.6% and 2.1%, respectively. They were followed by biotech firm Evaxion ( EVAX ) and pharmaceutical company Sanofi ( SNY ) , which were up 1.9% and 1.1%, respectively.

The decliners from continental Europe were led by telecommunications operator Telefonica ( TEFOF ) and pharmaceutical company Novo Nordisk ( NVO ) , which dropped 3.8% and 2.4%, respectively. They were followed by lender Banco Santander (SAN) and telecommunications company Nokia ( NOK ) , which lost 1.9% and 1.7%, respectively.

From the UK and Ireland, the gainers were led by biotech firm Autolus Therapeutics ( AUTL ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which advanced 7.8% and 6.1%, respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company NuCana ( NCNA ) , which increased 5.5% and 5.1%, respectively.

The decliners from the UK and Ireland were led by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and lender Lloyds Banking Group ( LYG ) , which fell 2.9% and 1.3%, respectively. They were followed by biopharmaceutical company Mereo BioPharma Group ( MREO ) and tobacco company British American Tobacco ( BTI ) , which were down 1.1% and 0.9%.

MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.

### Related Stocks

- [AUTL.US](https://longbridge.com/en/quote/AUTL.US.md)
- [CRTO.US](https://longbridge.com/en/quote/CRTO.US.md)
- [AKTX.US](https://longbridge.com/en/quote/AKTX.US.md)
- [NVO.US](https://longbridge.com/en/quote/NVO.US.md)
- [DBVT.US](https://longbridge.com/en/quote/DBVT.US.md)
- [BDRX.US](https://longbridge.com/en/quote/BDRX.US.md)

## Related News & Research

- [Novo Nordisk Receives UK Regulator Approval for Single-Dose 7.2mg of Wegovy](https://longbridge.com/en/news/282674972.md)
- [Key obesity drug figure departs Novo Nordisk](https://longbridge.com/en/news/282208420.md)
- [BREAKINGVIEWS-Weight loss drugs face first economic stress test](https://longbridge.com/en/news/282631128.md)
- [Health Rounds: Novo Nordisk weight-loss drug shows liver benefits in mouse study](https://longbridge.com/en/news/282732630.md)
- [Wegovy-maker Novo Nordisk partners with OpenAI to speed drug development](https://longbridge.com/en/news/282636425.md)